Literature DB >> 10379422

Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs.

J Fang1, J W Gorrod.   

Abstract

1. Antipsychotic drugs are extensively metabolised by cytochrome P450 (CYP) enzymes. 2. Dispositions of a number of antipsychotic drugs have been shown to cosegregate with polymorphism of CYP2D6. 3. Metabolic drug-drug interactions have frequently been observed when antipsychotics are coadministered with other drugs. 4. Many antipsychotic drugs are converted to active metabolites which can contribute to the therapeutic or side effects of the parent drug. 5. Information concerning the individual CYP isoenzymes involved in the metabolism of antipsychotic drugs is important for the safe clinical use of this group of drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379422     DOI: 10.1023/a:1006938908284

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  151 in total

1.  Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism.

Authors:  R Fonne-Pfister; U A Meyer
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

2.  Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients.

Authors:  M G Choc; F Hsuan; G Honigfeld; W T Robinson; L Ereshefsky; M L Crismon; S R Saklad; J Hirschowitz; R Wagner
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

3.  Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  C Swett
Journal:  Arch Gen Psychiatry       Date:  1974-08

Review 4.  Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications.

Authors:  J W Hubbard; K K Midha; E M Hawes; G McKay; S R Marder; M Aravagiri; E D Korchinski
Journal:  Br J Psychiatry Suppl       Date:  1993-12

5.  Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels.

Authors:  R Perrin; A Minn; J F Ghersi-Egea; M C Grassiot; G Siest
Journal:  Biochem Pharmacol       Date:  1990-11-01       Impact factor: 5.858

6.  Hypotension due to chlorpromazine. Relation to cigarette smoking, blood pressure, and dosage.

Authors:  C Swett; J O Cole; S C Hartz; S Shapiro; D Slone
Journal:  Arch Gen Psychiatry       Date:  1977-06

7.  Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance.

Authors:  M W Jann; S R Saklad; L Ereshefsky; A L Richards; C A Harrington; C M Davis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.

Authors:  G L Stimmel; I R Falloon
Journal:  J Clin Psychiatry       Date:  1983-11       Impact factor: 4.384

9.  Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

Authors:  B J Ring; J Catlow; T J Lindsay; T Gillespie; L K Roskos; B J Cerimele; S P Swanson; M A Hamman; S A Wrighton
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

10.  Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

View more
  6 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

Review 3.  Cardio-oncology/onco-cardiology.

Authors:  Robert A Hong; Takeshi Iimura; Kenneth N Sumida; Robert M Eager
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

4.  High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies.

Authors:  A Castensson; L Emilsson; P Preece; E E Jazin
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 5.  Biotransformation of post-clozapine antipsychotics: pharmacological implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

6.  Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation.

Authors:  Rujia Zhong; Feng Zhang; Zhen Yang; Yingrui Li; Qiang Xu; Huan Lan; Siegfried Lang; Lukas Cyganek; Elke Burgermeister; Ibrahim El-Battrawy; Xiaobo Zhou; Ibrahim Akin; Martin Borggrefe
Journal:  Front Cardiovasc Med       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.